Long-term Efficacy and Safety of Photobiomodulation in Dry Age-Related Macular Degeneration (LIGHTSITE III: 24-Month Analysis)
Multiwavelength PBM represents an interventional therapy that restores visual function and has potential disease-modifying effects in intermediate dry AMD.
Authors
- Samantha Xavier
- Allen C. Ho (ORCID: https://orcid.org/0000-0003-3921-608X)
- Stephanie E. Tedford (ORCID: https://orcid.org/0000-0001-7402-6789)
- Cindy L. Croissant
- David Warrow
- Phil Lavin
- Todd E. Schneiderman
- Clark E. Tedford
- Marion Rohit Munk
- René Rückert
- Diana V. Do
- Allen Y. Hu
- Richard B. Rosen
- Glenn J. Jaffe
- Eleonora Lad
- Victor Gonzalez
- David Boyer
Institutions
- Northwestern University (US)
- Pacific Northwest National Laboratory (US)
- Duke University (US)
- New York Eye and Ear Infirmary (US)
- University Hospital of Bern (CH)
- California Retina Consultants (US)
- Peninsula Cancer Center (US)
- Duke Medical Center (US)
- Retina Vitreous Associates Medical Group (US)
- Duke University Hospital (US)
- Orthopädische Praxis (DE)
- Cancer Institute of Florida (US)
- Smith-Kettlewell Eye Research Institute (US)
- Valley Retina Institute (US)
- Framingham State University (US)
- Wills Eye Hospital (US)
Publication Details
- Journal
- Retina
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1097/iae.0000000000004822
- Primary Topic
- Laser Applications in Dentistry and Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00